FDA’s Plan B Plan Fails To Appease Von Eschenbach Blockers

FDA's recent request to meet with Barr Labs about the proposed OTC switch of Plan B has not ensured smooth sailing for the confirmation process of Acting FDA Commissioner Andrew von Eschenbach